IL6 and COVID-19: Since IL-6 is a pivotal biomarker in COVID-19 disease progression (Henry et al., 2020; McElvaney et al., 2020), we examined IL-6 levels in HCoV-OC43-infected and -uninfected HCT-8 and MRC-5 cells.